Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19583402 | 1.00 | S1PR1 (0.63) | S1PR1S1PR3 | |
| SCHEMBL29874504 | 1.00 | S1PR1 (0.63) | S1PR1S1PR3 | |
| SCHEMBL29874910 | 0.99 | S1PR1 (0.64) | S1PR1S1PR3 | |
| SCHEMBL17815750 | 0.99 | S1PR1 (0.64) | S1PR1S1PR3 | |
| SCHEMBL19433003 | 0.94 | S1PR1 (0.57) | S1PR1S1PR3 | |
| SCHEMBL17815752 | 0.94 | S1PR1 (0.57) | S1PR1S1PR3 | |
| SCHEMBL29874210 | 0.94 | S1PR1 (0.57) | S1PR1S1PR3 | |
| SCHEMBL29874456 | 0.94 | S1PR1 (0.57) | S1PR1S1PR3 | |
| SCHEMBL19432993 | 0.91 | S1PR1 (0.62) | S1PR1S1PR3 | |
| SCHEMBL17815541 | 0.90 | S1PR1 (0.54) | S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170327439-A1 | DIHYDRONAPHTHALENE DERIVATIVE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2017-11-16 | — | — | US | disclosed |
| US-20170327439-A1 | DIHYDRONAPHTHALENE DERIVATIVE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170327439-A1 | DIHYDRONAPHTHALENE DERIVATIVE | S1PR5, LPAR5, S1PR1 | S1PR1 3/4885S1PR3 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.